carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
generic drug updates
December Generic Drug Releases
Released: 12/28/2011
By: Theron Mindek

Generic — Lipitor®

On November 30th, Watson launched the authorized generic version of Lipitor® (atorvastatin calcium) tablets. Watson has received all FDA approvals.
Lipitor® is a prescription medicine that is used along with a low-fat diet. It lowers the LDL ("bad") cholesterol and triglycerides in blood, and can raise HDL ("good") cholesterol as well. Lipitor can lower the risk for heart attack, stroke, certain types of heart surgery, and chest pain in patients who have heart disease or risk factors for heart disease such as age, smoking, high blood pressure, low HDL, or family history of early heart disease.

Generic — Caduet®

On November 30th, Mylan commenced shipping their AB rated version of Caduet® (amlodipine besylate, atoravastatin calcium) tablets marketed by Pfizer.
Caduet is a prescription drug that combines two medicines, Norvasc® (amlodipine besylate) and Lipitor® (atorvastatin calcium). Norvasc is used to treat high blood pressure (hypertension), chest pain (angina), or blocked arteries of the heart (coronary artery disease); Lipitor is used along with a low-fat diet to lower the LDL (“bad” cholesterol) and triglycerides in the blood. It can raise the HDL (“good” cholesterol) as well.

Generic — Combivir®

On December 27th, Teva Pharmaceuticals has received final FDA approval and began shipping lamivudine and zidovudine tablets, the generic version of GlaxoSmithKline’s branded product, Combivir®.
The combination of lamivudine and zidovudine is used to treat human immunodeficiency virus (HIV) in patients with or without acquired immunodeficiency syndrome (AIDS). Lamivudine and zidovudine are in a class of antiviral medications called synthetic nucleoside analogues

The above generics are in stock and available to all claimants covered by Carlisle Medical Home Delivery Pharmacy.


<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
copyright 2012 carlisle medical
disclaimer site map disclaimer